Rezolute, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Rezolute, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($74.41M) | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | ($68.46M) | Sep 17, 2025 |
| FY2024 | Jun 30, 2023 | ($51.79M) | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | ($41.06M) | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | ($20.90M) | Sep 15, 2022 |
| FY2021 | Jun 30, 2020 | ($20.33M) | Sep 15, 2021 |
| FY2020 | Jun 30, 2019 | ($30.45M) | Oct 13, 2020 |
| FY2019 | Jun 30, 2018 | ($29.86M) | Sep 10, 2019 |
| FY2018 | Jun 30, 2017 | ($20.28M) | Oct 15, 2018 |
| FY2017 | Jun 30, 2016 | ($14.94M) | Sep 22, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($79.89M) | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | ($70.42M) | Sep 17, 2025 |
| FY2024 | Jun 30, 2023 | ($55.99M) | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | ($41.84M) | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | ($22.89M) | Sep 15, 2022 |
| FY2021 | Jun 30, 2020 | ($20.52M) | Sep 15, 2021 |
| FY2020 | Jun 30, 2019 | ($25.94M) | Oct 13, 2020 |
| FY2019 | Jun 30, 2018 | ($28.73M) | Sep 10, 2019 |
| FY2018 | Jun 30, 2017 | ($20.32M) | Oct 15, 2018 |
| FY2017 | Jun 30, 2016 | ($14.95M) | Sep 22, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $61.53M | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | $55.74M | Sep 17, 2025 |
| FY2024 | Jun 30, 2023 | $43.81M | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | $32.49M | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | $14.99M | Sep 15, 2022 |
| FY2021 | Jun 30, 2020 | $14.45M | Sep 15, 2021 |
| FY2020 | Jun 30, 2019 | $19.08M | Oct 13, 2020 |
| FY2019 | Jun 30, 2018 | $17.28M | Sep 10, 2019 |
| FY2018 | Jun 30, 2017 | $12.09M | Oct 15, 2018 |
| FY2017 | Jun 30, 2016 | $9.45M | Sep 22, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($69.08M) | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | ($57.37M) | Sep 17, 2025 |
| FY2024 | Jun 30, 2023 | ($44.48M) | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | ($39.62M) | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | ($20.44M) | Sep 15, 2022 |
| FY2021 | Jun 30, 2020 | ($24.17M) | Sep 15, 2021 |
| FY2020 | Jun 30, 2019 | ($15.30M) | Oct 13, 2020 |
| FY2019 | Jun 30, 2018 | ($14.11M) | Sep 10, 2019 |
| FY2018 | Jun 30, 2017 | ($13.31M) | Oct 15, 2018 |
| FY2013 | Jun 30, 2013 | ($1.63M) | Sep 11, 2013 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jun 30, 2023 | $153.0K | Sep 19, 2024 |
| FY2020 | Jun 30, 2020 | $0 | Oct 13, 2020 |
| FY2020 | Jun 30, 2019 | $47.0K | Oct 13, 2020 |
| FY2019 | Jun 30, 2018 | $6.0K | Sep 10, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $175.49M | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | $132.74M | Sep 17, 2025 |
| FY2024 | Jun 30, 2023 | $123.72M | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | $152.42M | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | $42.61M | Sep 15, 2022 |
| FY2021 | Jun 30, 2020 | $10.97M | Sep 15, 2021 |
| FY2020 | Jun 30, 2019 | $12.25M | Oct 13, 2020 |
| FY2019 | Jun 30, 2018 | $2.50M | Sep 10, 2019 |
| FY2018 | Jun 30, 2017 | $10.63M | Oct 15, 2018 |
| FY2017 | Jun 30, 2016 | $10.90M | Sep 22, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $13.36M | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | $11.73M | Sep 17, 2025 |
| FY2024 | Jun 30, 2023 | $7.55M | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | $2.95M | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | $16.51M | Sep 15, 2022 |
| FY2021 | Jun 30, 2020 | $3.60M | Sep 15, 2021 |
| FY2020 | Jun 30, 2019 | $10.50M | Oct 13, 2020 |
| FY2019 | Jun 30, 2018 | $6.46M | Sep 10, 2019 |
| FY2018 | Jun 30, 2017 | $2.10M | Oct 15, 2018 |
| FY2017 | Jun 30, 2016 | $2.13M | Sep 22, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $162.13M | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | $121.00M | Sep 17, 2025 |
| FY2025 | Jun 30, 2023 | $116.17M | Sep 17, 2025 |
| FY2024 | Jun 30, 2022 | $149.47M | Sep 19, 2024 |
| FY2023 | Jun 30, 2021 | $26.10M | Sep 14, 2023 |
| FY2022 | Jun 30, 2020 | $7.37M | Sep 15, 2022 |
| FY2021 | Jun 30, 2019 | $1.75M | Sep 15, 2021 |
| FY2020 | Jun 30, 2018 | ($3.96M) | Oct 13, 2020 |
| FY2019 | Jun 30, 2017 | $8.53M | Sep 10, 2019 |
| FY2018 | Jun 30, 2016 | $8.77M | Oct 15, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | ($403.86M) | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | ($329.44M) | Sep 17, 2025 |
| FY2024 | Jun 30, 2023 | ($260.99M) | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | ($209.20M) | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | ($168.14M) | Sep 15, 2022 |
| FY2021 | Jun 30, 2020 | ($147.24M) | Sep 15, 2021 |
| FY2020 | Jun 30, 2019 | ($126.90M) | Oct 13, 2020 |
| FY2019 | Jun 30, 2018 | ($94.18M) | Sep 10, 2019 |
| FY2018 | Jun 30, 2017 | ($64.32M) | Oct 15, 2018 |
| FY2017 | Jun 30, 2016 | ($44.04M) | Sep 22, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $94.11M | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | $70.40M | Sep 17, 2025 |
| FY2024 | Jun 30, 2023 | $16.04M | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | $150.41M | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | $41.05M | Sep 15, 2022 |
| FY2021 | Jun 30, 2020 | $9.96M | Sep 15, 2021 |
| FY2020 | Jun 30, 2019 | $11.57M | Oct 13, 2020 |
| FY2019 | Jun 30, 2018 | $1.65M | Sep 10, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Jun 30, 2021 | $13.97M | Sep 15, 2022 |
| FY2021 | Jun 30, 2020 | $0 | Sep 15, 2021 |
| FY2019 | Jun 30, 2019 | $0 | Sep 10, 2019 |
| FY2019 | Jun 30, 2018 | $3.43M | Sep 10, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | (1) | Sep 17, 2025 |
| FY2024 | Jun 30, 2023 | (1) | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | (2) | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | (2) | Sep 15, 2022 |
| FY2014 | Jun 30, 2014 | (1) | Sep 30, 2014 |
| FY2014 | Jun 30, 2013 | (1) | Sep 30, 2014 |
| FY2013 | Jun 30, 2012 | 0 | Sep 11, 2013 |
| FY2013 | Dec 31, 2011 | 0 | Sep 11, 2013 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 0 | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | (1) | Sep 17, 2025 |
| FY2024 | Jun 30, 2023 | (1) | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | (2) | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | (2) | Sep 15, 2022 |
| FY2014 | Jun 30, 2014 | (1) | Sep 30, 2014 |
| FY2014 | Jun 30, 2013 | (1) | Sep 30, 2014 |
| FY2013 | Jun 30, 2012 | 0 | Sep 11, 2013 |
| FY2013 | Dec 31, 2011 | 0 | Sep 11, 2013 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | 87.00M | Sep 17, 2025 |
| FY2025 | Jun 30, 2024 | 53.25M | Sep 17, 2025 |
| FY2024 | Jun 30, 2023 | 36.83M | Sep 19, 2024 |
| FY2023 | Jun 30, 2022 | 33.58M | Sep 14, 2023 |
| FY2022 | Jun 30, 2021 | 8.35M | Sep 15, 2022 |
| FY2022 | Feb 17, 2021 | 8.40M | Sep 15, 2022 |
| FY2021 | Jun 30, 2020 | 5.87M | Sep 15, 2021 |
| FY2022 | Aug 31, 2019 | 1 | Sep 15, 2022 |
| FY2020 | Jun 30, 2019 | 4.21M | Oct 13, 2020 |
| FY2019 | Jun 30, 2018 | 62,166 | Sep 10, 2019 |